Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel once-daily basal insulin cleared for marketing in Japan

Oct. 22, 2003

Global agreement reached by Roche and Ipsen for GLP-1 analogue

Oct. 22, 2003

Spotlight on insulin, insulin analogues and insulin formulations

Oct. 22, 2003

Weight loss reported with Axokine in obese patients with type 2 diabetes

Oct. 22, 2003

Good safety profile described for the antiobesity drug AOD-9604 in humans

Oct. 22, 2003

Vasodilating effects of topical methyl nicotinate in diabetic patients

Oct. 21, 2003

Osteogenesis promoters and their use claimed by Yamanouchi

Oct. 21, 2003

Liraglutide has beneficial effects on food intake and body weight in obese minipigs

Oct. 20, 2003

SBIR grant funds development of niprisan for sickle cell disease

Oct. 20, 2003

FDA accepts for filing NDA for ultra-low-dose transdermal estrogen patch

Oct. 20, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...